An Observational Study to Evaluate Quality of Life (QoL) and Influence of Cognitive Status on QoL in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) During 2 Years Treatment With Rebif New Formulation (RNF)
Clinical trial NCT01110993 · COMPLETED
Trial details
- NCT number
- NCT01110993
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-11-01
- Primary completion
- 2013-09-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.